$P19 9-year experience in treatment of primary localized prostate cancer with robotic five-fraction ultra-hypofractionated radiotherapy$

P19 9-year experience in treatment of primary localized prostate cancer with robotic five-fraction ultra-hypofractionated radiotherapy

Saved in:

Bibliographic Details
Main Authors:	M. Mezeckis, E. Vjaters, M. Skromanis, V. Buryk, S. Strutinska, S. Ledina
Format:	Article
Language:	English
Published:	Elsevier 2025-07-01
Series:	European Urology Open Science
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666168325001697
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Acute toxicity outcomes in Egyptian early-stage breast cancer: ultra-hypofractionated versus hypofractionated radiotherapy
by: Ahmed Magdy, et al.
Published: (2025-05-01)

Hypofractionated Prostate Radiotherapy with or without Conventionally Fractionated Nodal Irradiation: Clinical Toxicity Observations and Retrospective Daily Dosimetry
by: Andrew M. McDonald, et al.
Published: (2012-01-01)

Hypofractionated Proton Boost Combined with External Beam Radiotherapy for Treatment of Localized Prostate Cancer
by: Silvia Johansson, et al.
Published: (2012-01-01)

Moderate-Hypofractionated Radical Radiotherapy for Early-Stage Prostate Cancer: A Propensity Score Matching Analysis Comparing Dose Fractionation Patterns
by: Yinjie Tao MD, et al.
Published: (2025-03-01)

Hypofractionated image-guided radiotherapy with 70 Gy in 28 fractions for prostate cancer confined to the pelvis: a single institute experience in Taiwan
by: Hui-Lei Mu, et al.
Published: (2025-01-01)

Implementation of ultra-hypofractionated radiotherapy for breast cancer in the Netherlands in 2020–2023, using registry data and questionnaires
by: Anouk H. Eijkelboom, et al.
Published: (2025-06-01)

Normal tissue complication probability modeling for late rectal bleeding after conventional or hypofractionated radiotherapy for prostate cancer
by: Christian A.M. Jongen, et al.
Published: (2025-01-01)

Hypofractionated Palliative Radiotherapy for Relapsed and Refractory High-Risk Neuroblastoma
by: Ellery Koelker-Wolfe, et al.
Published: (2025-02-01)

Elective pelvic nodal irradiation in elderly men treated with hypofractionated radiotherapy
by: Rachel M. Glicksman, et al.
Published: (2025-01-01)

HypoFocal SRT Trial: Ultra-hypofractionated focal salvage radiotherapy for isolated prostate bed recurrence after radical prostatectomy; single-arm phase II study; clinical trial protocol
by: Daniel Zwahlen, et al.
Published: (2024-01-01)

Post-treatment changes in bowel and urinary function in prostate cancer patients treated with moderate or ultra-hypofractionation: A prospective cohort study
by: W.D. Heemsbergen, et al.
Published: (2025-07-01)

Efficacy Analysis of Hypofractionated Radiotherapy for Oligometastatic Tumors: A Retrospective Study
by: Qian Sun MD, et al.
Published: (2025-01-01)

Tumor volume changes after stereotactic, hypofractionated and conventional radiotherapy in paragangliomas of head and neck
by: Paweł J. Polanowski, et al.
Published: (2024-09-01)

Impact on outcomes of ultra hypofractionation or hypofractionation regimens and proton or Xrays therapy in a phase III randomized controlled trial MC1635
by: Carlos Vargas, et al.
Published: (2025-08-01)

A Phase I/II Study of Ultra-Hypofractionated Carbon-ion Radiation therapy for Low- and Intermediate-Risk Localized Prostate Cancer
by: Noriyuki Okonogi, MD, PhD, et al.
Published: (2025-03-01)

Hypofractionated radiotherapy regimens after organ-sparing surgery for stages I–IIa breast cancer
by: Yu. V. Efimkina, et al.
Published: (2014-08-01)

Radiotherapy-Induced Lung Cancer Risk in Breast Cancer Patients: A Retrospective Comparison of Hypofractionated and Standard Fractionated 3D-CRT Treatments
by: Alessia D’Anna, et al.
Published: (2025-07-01)

Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL)
by: Vedang Murthy, et al.
Published: (2020-02-01)

Use of hypofractionated radiotherapy regimens after organ-sparing surgery for Stages I–IIA breast cancers
by: Yu. V. Efimkina, et al.
Published: (2014-08-01)

Analysis of safety of postoperative accelerated hypofractionated radiotherapy for patients with stage I-IIIA breast cancer
by: G. V. Afonin, et al.
Published: (2020-04-01)

Hypofractionated versus conventional radiotherapy for head-and-neck cancer: A systematic review and meta-analysis
by: Arnab Roy, et al.
Published: (2025-01-01)

Clinical outcomes and prognostic factors of repeated conventional hypofractionated radiotherapy for recurrent intranasal tumors in dogs
by: Hirona Ueno, et al.
Published: (2025-02-01)

Investigation of Ki-67 and Clinical Outcome in Feline Nasal Adenocarcinoma Treated Using Hypofractionated Radiotherapy
by: Premkamon Aonta, et al.
Published: (2024-12-01)

Robotic Radical Prostatectomy in Patients with Previous Prostate Surgery and Radiotherapy
by: Ömer Acar, et al.
Published: (2014-01-01)

Local control and possibility of tailored salvage after hypofractionated stereotactic radiotherapy of the cavity after brain metastases resection
by: Angelika Bilger, et al.
Published: (2018-06-01)

Hypofractionated radiotherapy for newly diagnosed elderly glioblastoma patients: A systematic review and network meta-analysis.
by: Suely Maymone de Melo, et al.
Published: (2021-01-01)

A Prospective Study to Assess Response and Toxicity of Hypofractionated Palliative Radiotherapy in Advanced Inoperable Oropharyngeal Carcinoma
by: Ayush Naik, et al.
Published: (2025-07-01)

Phase II single vs hypofractionated irradiation for timely access to partial breast radiotherapy (SHIFT-PB)
by: Robert Olson, et al.
Published: (2025-08-01)

Carcinoma buccal mucosa treated with definitive hypofractionated accelerated radiotherapy: a retrospective analysis of treatment outcomes
by: Geethu Babu, et al.
Published: (2025-07-01)

Hypofractionated radiotherapy (RT) combined with dihydroartemisinin (DHA): No synergistic effect observed in a preliminary animal study
by: Yuenan Wang, et al.
Published: (2025-03-01)

Hypofractionated Postmastectomy Radiotherapy (HF-PMRT): What did We Learn from COVID-19 Era?
by: Viola Salvestrini, et al.
Published: (2023-02-01)

An accelerated hypofractionated radiotherapy regimen in patients after organ-sparing surgery for stages I–IIA breast cancer
by: I. A. Gladilina, et al.
Published: (2016-11-01)

Long-Term Outcomes After High-Dose-Rate Brachytherapy and Hypofractionated External Beam Radiotherapy in Very High-Risk Prostate Cancer: A 24-Year Follow-Up
by: Pedro J. Prada Gómez, et al.
Published: (2025-05-01)

Comments on: Carcinoma buccal mucosa treated with definitive hypofractionated accelerated radiotherapy: a retrospective analysis of treatment outcomes
by: Efsun Somay, et al.
Published: (2025-07-01)

Early Dynamics of Circulating Tumor DNA Following Curative Hypofractionated Radiotherapy Related to Disease Control in Lung Cancer
by: Kyungmi Yang, et al.
Published: (2025-05-01)

Hypofractionated stereotactic radiotherapy using coplanar VMAT for single small brain metastasis: dosimetric analysis and clinical outcomes
by: Jialu Lai, et al.
Published: (2025-02-01)

Verteporfin‐Mediated In Situ Nanovaccine Based on Local Conventional‐Dose Hypofractionated Radiotherapy Enhances Antitumor and Immunomodulatory Effect
by: Zhifan Zhang, et al.
Published: (2025-05-01)

Case Report: Proximal bronchial injury in small-cell lung cancer patient after moderately hypofractionated radiotherapy
by: Tongsong Zhang, et al.
Published: (2025-05-01)

Phase II Trial of Hypofractionated Radiotherapy and Immunochemotherapy in Primary Refractory Diffuse Large B‐Cell Lymphoma: Preliminary Results and Insights from Digital Spatial Profiling
by: Yong Yang, et al.
Published: (2025-06-01)

A comparative analysis of hypofractionated versus conventional radiotherapy for cervical cancer in a resource-limited setting: a prospective study
by: Abba Mallum, et al.
Published: (2025-06-01)